ScoreWhy is Bandaram Pharma Packtech Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.33%
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.87 times
2
Stock is technically in a Mildly Bearish range
- The stocks MACD and KST technical factors are also Bearish
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.61% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -22.87% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bandaram Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Bandaram Pharma
-23.26%
-0.29
79.43%
Sensex
-5.16%
-0.39
13.26%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.44%
EBIT Growth (5y)
32.07%
EBIT to Interest (avg)
1.54
Debt to EBITDA (avg)
7.75
Net Debt to Equity (avg)
0.87
Sales to Capital Employed (avg)
1.21
Tax Ratio
31.17%
Dividend Payout Ratio
12.07%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
4.85%
ROE (avg)
4.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
160
Industry P/E
93
Price to Book Value
1.97
EV to EBIT
33.72
EV to EBITDA
26.07
EV to Capital Employed
1.52
EV to Sales
1.21
PEG Ratio
NA
Dividend Yield
0.04%
ROCE (Latest)
4.50%
ROE (Latest)
1.23%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
PAT(Latest six months)
Higher at Rs 0.28 cr
NET SALES(Q)
Highest at Rs 26.26 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Bandaram Pharma
Net Sales - Quarterly
At Rs 26.26 cr has Grown at 209.31%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
Higher at Rs 0.28 cr
than preceding 12 month period ended Mar 2026 of Rs 0.19 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 26.26 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
